生物
毒力
选择(遗传算法)
抗药性
计算生物学
实验进化
抗性(生态学)
药品
药物开发
病菌
遗传学
基因
生态学
药理学
计算机科学
人工智能
作者
Richard C. Allen,Roman Popat,Stephen P. Diggle,Sam P. Brown
摘要
Antivirulence drugs are a new type of therapeutic drug that target virulence factors, potentially revitalising the drug-development pipeline with new targets. As antivirulence drugs disarm the pathogen, rather than kill or halt pathogen growth, it has been hypothesized that they will generate much weaker selection for resistance than traditional antibiotics. However, recent studies have shown that mechanisms of resistance to antivirulence drugs exist, seemingly damaging the 'evolution-proof' claim. In this Opinion article, we highlight a crucial distinction between whether resistance can emerge and whether it will spread to a high frequency under drug selection. We argue that selection for resistance can be reduced, or even reversed, using appropriate combinations of target and treatment environment, opening a path towards the development of evolutionarily robust novel therapeutics.
科研通智能强力驱动
Strongly Powered by AbleSci AI